When a Tau PET Scan Is Abnormal: What Comes Next in Dementia Testing?

Understand abnormal tau results and the follow-up tests that guide Alzheimer's diagnosis, treatment talks, and planning.

An abnormal tau PET scan shows tau tangles but does not by itself diagnose Alzheimer's disease. What comes next is amyloid confirmation when unknown, clinical correlation, and a clear care plan. A tau PET scan is a brain imaging test that maps tangles, twisted tau proteins that injure brain cells.

It uses flortaucipir F-18 (Tauvid) to estimate the density and spread of aggregated tangles in adults with cognitive impairment. The FDA label published by the U.S. National Library of Medicine DailyMed describes this use for people being evaluated for Alzheimer's disease FDA label for Tauvid. An abnormal result marks advanced tau pathology, but diagnosis still needs amyloid evidence and matching symptoms.

Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.

Table of Contents

Does abnormal tau mean Alzheimer's?

The 2024 Alzheimer's Association Workgroup defines Alzheimer's biologically by core amyloid and tau markers. Amyloid PET, spinal fluid, or plasma p-tau217 act as early Core 1 signals. Tau PET acts as Core 2 staging pathology. That split matters for families.

Plaques can appear years before tangles spread and thinking changes. Doctors use tau burden to stage disease, not to start therapy alone. Reading has limits. The DailyMed FDA precautions note Tauvid uses visual reading and is not indicated for chronic traumatic encephalopathy. A negative scan also needs added evaluation to exclude Alzheimer's pathology.

Which test confirms amyloid status?

When amyloid status is unknown, doctors confirm it after abnormal tau PET, according to a PMC review of the 2024 criteria PMC review of the 2024 criteria. Options are amyloid PET, spinal fluid Aβ42/40, or a validated blood test. Alzheimer's diagnosis usually needs both plaques and tangles plus a compatible cognitive syndrome.

For example, abnormal tau plus positive amyloid with memory loss supports Alzheimer's. Abnormal tau with negative amyloid points toward another brain disease. Mixed results can mean more than one disease is active.

How do doctors build the full diagnosis?

The Alzheimer's Association DETeCD-ADRD guideline calls for a three-step formulation. Doctors define level of impairment, name the cognitive-behavioral syndrome, then judge likely brain disease or diseases. Tau results enter only with exam, MRI, labs, and functional assessment.

This step prevents overreading one scan. Depression, sleep apnea, vitamin deficiency, thyroid disease, and medicines can worsen thinking. MRI shows vascular injury or shrinkage, while history shows daily impact.

What care and treatment talks follow?

People with mild cognitive impairment or mild dementia and confirmed amyloid may be evaluated for anti-amyloid antibodies lecanemab and donanemab, approved in 2023 and July 2024, according to a Diagnostics review Diagnostics review of testing and treatment. Tau burden helps stage disease and inform trial or treatment talks. Eligibility also weighs risks, other illnesses, and patient goals.

The Alzheimer's Association DETeCD decision guide outlines practical next steps for disclosure and planning. Clinics tailor them to symptoms, support, and patient wishes. Bring a medication list, a family member who sees daily function, and questions about work and driving. Ask for a written summary, safety plan, and referral date before you leave.

  • structured result disclosure and care planning
  • APOE testing and baseline MRI if therapy is considered
  • safety counseling on driving, work, and home risks
  • referral to a dementia specialist or clinical trial

You Might Also Like

HelpDementia.com

Dementia, Alzheimer's, Caregiving & Healthy Aging Guidance

© 2026 HelpDementia.com. All rights reserved.

Educational information only. It is not medical advice and does not replace care from a qualified clinician.